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Exposure to combat-related trauma often leads to lifetime functional impairments.
Previous research demonstrated the effects of oxytocin (OT) administration on
brain regions implicated in post-traumatic stress disorder (PTSD); yet OT’s effects
on brain patterns in trauma-exposed veterans have not been studied. In the
current study the effects of OT on spontaneous brain oscillatory activity were
measured in 43 veterans using magnetoencephalography (MEG): 28 veterans who
were exposed to a combat-related trauma and 15 trauma-unexposed controls.
Participants participated in two experimental sessions and were administered
OT or placebo (PBO) in a double-blind, placebo-control, within-subject design.
Following OT/PBO administration, participants underwent a whole-head MEG
scan. Plasma and salivary OT levels were assessed each session. Spontaneous
brain activity measured during a 2-min resting period was subjected to source-
localization analysis. Trauma-exposed veterans showed higher resting-state alpha
(8–13 Hz) activity compared to controls in the left dorsolateral prefrontal cortex
(dlPFC), specifically in the superior frontal gyrus (SFG) and the middle frontal
gyrus (MFG), indicating decreased neural activity in these regions. The higher
alpha activity was “normalized” following OT administration and under OT, group
differences were no longer found. Increased resting-state alpha was associated
with lower baseline plasma OT, reduced salivary OT reactivity, and more re-
experiencing symptoms. These findings demonstrate effects of OT on resting-state
brain functioning in prefrontal regions subserving working memory and cognitive
control, which are disrupted in PTSD. Results raise the possibility that OT,
traditionally studied in social contexts, may also enhance performance in cognitive
tasks associated with working memory and cognitive control following trauma
exposure.
Keywords: oxytocin, MEG, alpha oscillations, dorsolateral prefrontal cortex (dlPFC), PTSD, veterans
Abbreviations: OT, Oxytocin; PBO, placebo; dlPFC, dorsolateral prefrontal cortex; SFG, superior frontal gyrus; MFG,
middle frontal gyrus.
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Introduction
Combat-related post-traumatic stress disorder (PTSD) is a
debilitating disorder that often leads to lifetime impairments
in cognitive processing, social relationships, and emotion
regulation (Yehuda, 2002; American Psychiatric Association,
2013). Prevalence studies have shown that between 2 and
17% of US veterans develop PTSD (Richardson et al., 2010),
particularly those who witnessed injury or death of another
person (Smith et al., 2008). Furthermore, many veterans
show substantial functional impairment, work and family
problems, and dramatic reduction in quality of life even
decades after combat (Schnurr et al., 2009). These are also
observed in veterans who do not meet full criteria for PTSD
(Schnurr et al., 2000; Grubaugh et al., 2005; Jakupcak et al.,
2007).
Research has shown significant alterations in brain structure
and function in cases of PTSD in a number of regions, including
the amygdala and the prefrontal cortex (PFC; Karl et al., 2006;
Hayes et al., 2012; Pitman et al., 2012). Functional neuroimaging
studies using different paradigms, such as symptom provocation
or cognitive and emotional tasks, have demonstrated hyper-
activation of the amygdala (Liberzon et al., 1999; Rauch et al.,
2000; Bryant et al., 2005; Fonzo et al., 2010; Simmons et al.,
2011) and hypo-activation of the PFC (Shin et al., 2001; Lanius
et al., 2003; Williams et al., 2006; Milad et al., 2009), and
some have shown inversed relation of activity (Shin et al.,
2004, 2005) and abnormal connectivity (Stevens et al., 2013)
between the amygdala and the PFC. Comparable findings were
also observed during a resting-state, i.e., in the absence of
task demands (Chung et al., 2006; Sripada et al., 2012; Yan
et al., 2013). It has been suggested that amygdala hyper-
responsivity and impaired top-down prefrontal control mediate
the dysregulation of fear and threat-related processing in PTSD
(Rauch et al., 2006). More recently it has been proposed (Patel
et al., 2012) that abnormalities in three different neuro-cognitive
networks may explain the range of symptoms seen in PTSD.
One of these networks, the central executive network (Menon,
2011), is associated with high-level cognitive functions, such
as decision making, attention control, and working memory,
and is anchored in the dorsolateral prefrontal cortex (dlPFC),
a region critical to proper cognitive control over emotions
(Ochsner et al., 2002; Phan et al., 2005). Thus, processes typical
of PTSD such as negative appraisals of stimuli, as well as the
disrupted cognitive functioning seen in PTSD, may be related
to aberrant top-down signaling from this network (Patel et al.,
2012).
Decreased activity in the dlPFC has been observed in PTSD
during the performance of cognitive tasks (Clark et al., 2003;
Falconer et al., 2008; Rabinak et al., 2014) and during a resting-
state (Yan et al., 2013) and such decrease is associated with PTSD
symptom severity (Falconer et al., 2008; Yan et al., 2013). Studies
assessing the effects of therapy on brain function in PTSD have
shown that positive effects were associated with activation in
frontal regions, including the dlPFC (Cohen et al., 2004; Farrow
et al., 2005; Peres et al., 2007; Lindauer et al., 2008; Boggio et al.,
2010; Watts et al., 2012; Thomaes et al., 2014). These studies
suggest that the dlPFC may be a target region for intervention
effort in PTSD and that improved functioning in this region may
serve as an index of positive therapeutic effects.
Intranasal administration of oxytocin (OT), a nine-amino-
acid neuropeptide implicated in mammalian caregiving and
sociality (Feldman, 2012; Carter, 2014), has been shown to
exert regulatory effects on brain patterns in healthy individuals
exposed to threatening stimuli and in individuals with a variety
of psychiatric conditions due to its anxiolytic properties (Meyer-
Lindenberg et al., 2011; Bethlehem et al., 2013; Weisman and
Feldman, 2013; MacDonald and Feifel, 2014). The anxiolytic
and stress protective effects of OT have been demonstrated in
animal (Windle et al., 2004; Blume et al., 2008; Viviani et al.,
2011; Peters et al., 2014) and human (Heinrichs et al., 2003;
Light et al., 2005; Gordon et al., 2008; Ditzen et al., 2009)
research. In animals, research has shown that the induction of
endogenous OT release from the central amygdala decreases
fear responses (Knobloch et al., 2012). In humans, anxiolytic
effects have been demonstrated by the attenuation of amygdala
activation to fearful stimuli following OT administration, as
observed in functional MRI studies with healthy adults (Kirsch
et al., 2005; Domes et al., 2007). In addition, OT has been
shown to increase resting-state functional connectivity between
the amygdala and frontal regions that are critical for fear
extinction and regulation of emotions (Sripada et al., 2013),
further supporting its anti-stress effects. The anxiolytic and
stress reducing properties of OT have been suggested as
one mechanism that underpins the well-established pro-social
effects of OT in humans (Churchland and Winkielman, 2012;
MacDonald and Feifel, 2013).
Studies utilizing intranasal OT administration in clinical
populations have shown that OT improved core symptoms and
aberrant brain patterns in cases of schizophrenia (Feifel et al.,
2010), autism (Domes et al., 2013; Gordon et al., 2013), and social
anxiety (Labuschagne et al., 2010; Dodhia et al., 2014). Studies
have also shown that OT administration improved symptom
severity (Yatzkar and Klein, 2010) and reduced the physiological
response to combat imagery (Pitman et al., 1993) in PTSD.
The effects of OT administration on reducing the amygdala
fear-response (Kirsch et al., 2005; Domes et al., 2007) and on
increasing amygdala-prefrontal connectivity in healthy adults
(Sripada et al., 2013) and in adults with generalized social anxiety
disorder (Dodhia et al., 2014), suggest that OT may exert a
regulatory function on brain patterns following exposure to
combat-related trauma.
In light of the above, the current study examined the effects of
OT administration on spontaneous (resting-state) brain activity
in trauma-exposed war veterans. Spontaneous activity has been
used to examine the intrinsic functional activity of the brain
(Raichle and Mintun, 2006) and has been shown to index
risk for various psychiatric disorders including PTSD (Buckner
and Vincent, 2007). In PTSD, abnormal oscillatory activity in
frontal regions and in the insula was found during resting-state
in trauma-exposed individuals using magnetoencephalography
(MEG; Kolassa et al., 2007). In another MEG study, resting-
state activity differentiated patients from controls, suggesting
that spontaneous brain patterns may serve as neuromarkers
Frontiers in Behavioral Neuroscience | www.frontiersin.org 2 June 2015 | Volume 9 | Article 165
Eidelman-Rothman et al. Oxytocin, spontaneous brain activity, and trauma-exposure
for the disorder (Georgopoulos et al., 2010). Brain oscillations
reflect synchronized activity of large populations of neurons
and support normal brain function (Buzsáki and Draguhn,
2004). In the current study, we were particularly interested
in alpha rhythm, the predominant oscillatory frequency in
humans during eyes-closed rest (Nunez et al., 2001). Alpha
activity has been associated with decreased cortical activity
(Goldman et al., 2002; Laufs et al., 2003a; Jensen and
Mazaheri, 2010), and anomalies in resting-state alpha have
been observed in various psychiatric disorders (Ciesielski et al.,
2007; Hinkley et al., 2011; Cornew et al., 2012), including
combat-related PTSD (Joki´c-begi´c and Begi´c, 2003; Huang et al.,
2014).
We further measured whether post-traumatic symptoms
and peripheral OT levels may be associated with the effects
of OT administration on spontaneous oscillatory brain
patterns.
Materials and Methods
Participants
At the first stage of the study, 190 young male veterans (age
< 35 years) were recruited. These included 158 veterans who
served in the Israel Defense Force (IDF) in active combat units
during the past 8 years, participated in active battle that involved
life endangerment, and witnessed injury or death of a comrade.
Thirty-two veterans matched for age and education, who served
in the IDF during the same period in non-combat units (e.g.,
intelligence, technical support) and were not exposed to active
combat were recruited as controls. All veterans completed the
Post-Traumatic Stress Diagnostic Scale (PDS; Foa et al., 1997)
for the assessment of post-traumatic symptom severity and in
order to ensure that members of the control group were free
of post traumatic symptoms. Twenty-eight veterans from the
trauma-exposed group with non-zero PDS scores (mean age
= 27 years, SD = 1.81) and 16 controls with 0 PDS scores
(mean age = 28.94 years, SD = 3.02) who met inclusion criteria
participated in the OT administration and MEG study, as
described below. Most members of the trauma-exposed group
experienced the traumatic event 3 or 5 years before the study,
during two distinct military operations, and the others in various
other operations in the period between 3 to 8 years before the
study.
Participants were recruited via advertisement in the
community and were matched for demographic status.
Subjects were right-handed as measured by the Edinburgh
Handedness Questionnaire except for three subjects from the
exposed group who were neutral (N = 1) or left handed (N =
2). Exclusion criteria included serious physical injury, current
or past neurological disorders, serious medical problems, and
regular use of medication. War-exposed veterans were not
exposed to trauma other than combat. Control veterans were not
exposed to trauma of any kind and had no present psychiatric
disorder. The study was approved by the Institutional Review
Board of Bar-Ilan University and after complete description
of the study, written informed consent was obtained from all
participants.
Experimental Procedure
Clinical Diagnosis
All participants were diagnosed by clinical psychologists blind to
trauma history supervised by a psychiatrist using the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I;
First et al., 1997). Among controls, none received any Axis-I
psychiatric diagnosis. Among trauma-exposed veterans 11 were
diagnosed with PTSD and five of them showed co-morbidity
which included depression (N = 3), dysthymia (N =‘2), phobia
(N = 2), panic attacks (N = 1), and OCD (N =‘2). Trauma-
exposed veterans who did not meet criteria for a full PTSD
diagnosis showed no difference in their post-traumatic symptom
scores in any symptom cluster (re-experience, avoidance, hyper-
arousal) or in the functional impairment domain on the PDS.
Mean PDS symptom severity scores were 19.72 (SD = 9.12) for
trauma-exposed veterans who met DSM-IV criteria for a full
PTSDAxis-I diagnosis and 16.13 (SD = 7.22) for trauma-exposed
veterans who did not meet criteria for full PTSD diagnosis
(F(1,25) = 1.25, NS). We therefore combined the two groups into
a single group. This is consistent with the DSM-V approach,
which advocates a dimensional approach to psychiatric disorders
as indexed by symptom severity profiles (American Psychiatric
Association, 2013).
Experimental Design
The study employed a double-blind, placebo (PBO)-control,
within-subject design. Each subject participated in two similar
experimental sessions approximately a week apart (mean
= 7.5 days, SD = 2). Baseline (T1) blood and saliva
samples were collected in each session. Following, participants
self-administered 24 IU of either OT (Syntocinon Spray,
Novartis, Switzerland; three puffs per nostril, each containing
4 IU) or PBO. PBO was custom-designed by commercial
compounding pharmacy to match drug minus the active
ingredient. Administration order was counterbalanced, and
participants and experimenters were blind to drug condition.
Experimental sessions were conducted between 14:30 and
16:00 pm to accommodate diurnal variations in OT.
Forty-five minutes after OT/PBO administration,
spontaneous brain activity was measured using MEG during a
2 min period when subjects rested with their eyes closed. Two
additional saliva samples were collected in each experimental
session, one before (T2) and one after (T3) the MEG scanning.
Brain Activity Recording and Analysis
MEG recordings were conducted with a whole-head, 248-
channel magnetometer array (4-D Neuroimaging, Magnes 3600
WH) in a magnetically-shielded room with a sample rate of
1017 Hz and online 1–400 Hz band-pass filter in a supine
position. External noise (e.g., power-line, mechanical vibrations)
and heartbeat artifacts were removed from the data as previously
described (Tal and Abeles, 2013). Signal pre-processing at the
sensor level was carried out using MATLAB and the FieldTrip
toolbox (Oostenveld et al., 2011). The data were segmented
into 1000 ms epochs, filtered in the 1–80 Hz range with 10 s
padding and were baseline-corrected. The data epochs were
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visually inspected for eye movement and muscle artifacts which
were excluded from further analysis.
For source estimation, a template MRI (Collin27) was
modified to fit each subject’s digitized head shape using
SPM8 (Wellcome Department of Imaging Neuroscience,
University College London, London, UK).1 Synthetic aperture
magnetometry (SAM) beamformer (Robinson and Vrba,
1999) was applied with a spatial resolution of 0.5 cm for each
experimental condition (OT or PBO) at four frequency bands:
delta (1–4 Hz), theta (4–8 Hz), alpha (8–13 Hz) and beta (13–20
Hz). Individual source power maps were reconstructed using
pseudo-Z statistic. Following transformation into a common
coordinate space (Talairach) clusters with significant effects
were identified by a voxel-level t-test and were corrected for
multiple comparisons based on a Monte Carlo simulation of
random noise distribution (Forman et al., 1995). The results
were superimposed on the MRI template as statistical maps,
showing regions of statistically significant difference in activity.
The voxel average activity in clusters with significant group
differences at baseline (under PBO) was used in the following
analyses.
Oxytocin Collection and Determination
Blood was drawn at baseline, before OT/PBO administration,
during each visit from antecubital veins into ninemilliliter chilled
vacutainer tubes containing lithium heparin supplemented with
400 KIU of Trasylol (Trasylol–Bayer, Germany) per one milliliter
blood. Blood samples were kept ice-chilled for up to 2 h before
centrifuged at 4◦C at 1000 × g for 15 min. Supernatants were
collected and stored at−80◦C until assayed.
Saliva samples were collected three times each visit as
described above. OT from saliva was collected by Salivate
(Sarstedt, Rommelsdorft, Germany). Salivates were kept ice-
chilled for up to 1 h before centrifuged at 4◦C at 1500 × g for 15
min. Liquid samples were stored at −80◦C. To concentrate the
samples by 3–4 times, liquid samples were lyophilized over-night
and kept in−20◦Cuntil assayed. Dry samples were reconstructed
in the assay buffer immediately before analysis by OT EIA
commercial Kit, consistent with previous research (Feldman
et al., 2010).
Determination of OT was performed using commercial
ELISA kit (Assay Design, MI, USA; through ENZO, NY,
USA), consistent with our previous research (Feldman et al.,
2011; Weisman et al., 2013). Measurements were performed
in duplicate and concentration of samples calculated using
MATLAB according to relevant standard curves. The intra-assay
and inter-assay coefficients were<12.3 and<14.5%, respectively.
Immunoassay methods (EIA/ELISA) for the quantitative
determination of OT and is considered the gold standard
in current OT research and has shown to be sensitive
and reliable (Kramer et al., 2004), and unlike the earlier
radioimmunoassay (RIA) method it does not involve the use of
radioactive substances (but note several methodological issues,
see ‘‘Limitations’’ Section).
Two measures of peripheral OT were computed:
1www.fil.ion.ucl.ac.uk
Baseline plasma OT was the average of baseline (T1) OT
levels in the two visits, which were highly correlated, (r
= 0.97, p< 0.0001).
Salivary OT reactivity was measured as the increase in OT
from baseline (T1) after OT administration (T2 + T3 2
minus T1 in the OT session).
Results
Group Differences in Spontaneous Brain Activity
Under Placebo
Analysis was first performed for the PBO condition in order to
assess group differences in spontaneous brain activity at baseline.
Group differences were found only in alpha-band activity (8–13
Hz), located in a cluster of two regions within the left dlPFC
(Figure 1A): the left superior frontal gyrus (SFG) and the left
middle frontal gyrus (MFG). In these regions, the trauma-
exposed group showed increased alpha activity compared to the
control group (Figure 1B; F(1,40) = 6.88, p = 0.014, and F(1,40) =
5.82, p = 0.021, for SFG and MFG, respectively).
Effects of Oxytocin on Spontaneous Brain
Activity
In the next stage, we tested the effect of OT administration
on alpha activity in the two dlPFC regions that showed group
differences at PBO, the left SFG and the left MFG. A repeated
measure analysis of variance (ANOVA) showed a significant
interaction effect of group and OT administration for both
the SFG (F(1,38) = 5.76, p = 0.021), and the MFG (F(1,38)
= 4.89, p = 0.033), indicating that OT’s effect differed by
group (Figure 2). Specifically, OT administration significantly
decreased the heightened alpha activity among trauma-exposed
veterans, and under OT, group differences were no longer found.
In the control group however, OT increased the alpha activity,
but this finding was not statistically significant.
Peripheral Oxytocin
No differences were found between groups in plasma and salivary
OT levels at baseline or in OT reactivity.
Spontaneous Alpha Activity, Peripheral Oxytocin
and Symptom Severity
Alpha activity at baseline (at PBO) correlated with peripheral
measures of OT for the entire sample and with symptom severity
in the trauma-exposed group. Higher alpha in the left SFG
was associated with lower levels of baseline plasma OT (r =
−0.38, p = 0.014), and higher alpha in the left MFG was
associated with lower salivary OT reactivity (r = −0.35, p =
0.025). Interestingly, more re-experiencing symptoms correlated
with higher baseline alpha in both the left SFG, (r = 0.43, p =
0.027), and the left MFG, (r = 0.39, p = 0.045). Re-experiencing
symptoms index the uncontrolled re-living of the trauma in the
form of thoughts and images of the traumatic event, nightmares,
flashbacks, psychological distress and physiological reactivity to
trauma-reminders.
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FIGURE 1 | Between-group differences in spontaneous brain activity at
baseline (placebo). (A) Dorsolateral prefrontal cluster of the left superior frontal
gyrus (SFG) and the left middle frontal gyrus (MFG) showing higher alpha activity
in the trauma-exposed group compared to the control group, p < 0.05,
corrected. x, y, z of maximal voxels in Montreal Neurological Institute (MNI)
coordinates = −17, 59, 22 and −27, 64, 27, for SFG and MFG, respectively.
Averaged alpha activity over all voxels in the SFG and in the MFG (B).
*p < 0.05. Error bars represent SEM.
FIGURE 2 | The effects of oxytocin (OT) administration on spontaneous
alpha activity. Averaged alpha activity over all voxels in the left SFG and in
the left MFG in the placebo and OT conditions. *p < 0.05. Error bars represent
SEM.
Discussion
Results of the current study, the first to test the brain
response of trauma-exposed veterans to OT administration,
demonstrate that OT significantly attenuated the aberrant
alpha activity in dorsolateral prefrontal regions implicated in
working memory and cognitive control, in trauma-exposed
veterans. Spontaneous oscillations in the alpha range are
the predominant electrophysiological signal in healthy adults
during rest when the attention system is not recruited toward
a specific task (Nunez et al., 2001). Alpha oscillations are
associated with decreased cortical activity, are thought to
reflect functional inhibition (Jensen and Mazaheri, 2010), and
are negatively correlated with the strength of BOLD fMRI
signal in frontal and parietal cortical areas that support
attention and related cognitive processes (Laufs et al., 2003b).
This suggests that higher alpha power provides an index
of decreased cortical activity in these regions, and our
findings suggest that OT may have some impact, albeit
momentarily, on prefrontal structures suggested as among those
underpinning the functional impairment in PTSD (Patel et al.,
2012).
Specifically, we found that OT attenuated the increased
alpha power observed among trauma-exposed veterans in two
frontal regions, the left SFG and the left MFG. Neuroimaging
and human lesion studies indicated that both the SFG
and MFG are critical for working memory and cognitive
control (Aron et al., 2004; Egner and Hirsch, 2005; du
Boisgueheneuc et al., 2006; Jurado and Rosselli, 2007). In
patients with left SFG lesion, impairments to working memory
increased as the task demands became more complex (du
Boisgueheneuc et al., 2006) and in patients with left MFG
lesion (Aron et al., 2004) the degree of cognitive control
impairments correlated with the extent of damage to this
region. Studies have repeatedly shown dysfunction in working
memory (Elzinga and Bremner, 2002), attention, and cognitive
control (Banich et al., 2009) in patients with PTSD, including
combat-related PTSD (Vasterling et al., 1998). Our findings,
therefore, raise the possibility that OT, which has been
studied almost entirely in the social context, may also act
to enhance performance in cognitive tasks associated with
working memory and cognitive control which are disrupted
in PTSD or may be used in conjunction with cognitive-
behavior therapy, but this hypothesis is only preliminary
and requires much further systematic research in larger
samples.
The difficulties seen in PTSD patients in working memory,
attention, and cognitive control (Banich et al., 2009) have
been shown to index PFC disturbances. Neuroimaging studies
found hypo-activity of the PFC, hyper-activity of the amygdala
(Hayes et al., 2012; Pitman et al., 2012), and inverse relation of
activity in the amygdala and the PFC (Shin et al., 2004, 2005)
in cases of PTSD. Abnormal activity in the central executive
network, a brain network which is situated in the dlPFC and
is associated with high-level cognitive functions (Menon, 2011),
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has been implicated in some of the behavioral difficulties in
PTSD (Patel et al., 2012). The increase in activity in the left
SFG and MFG following OT administration, indexed by the
decrease in alpha activity found here, may suggest that OT
exerts anxiolytic effects by enhancing activity in an attention-
related network implicated in the application of cognitive, goal-
directed selection to sensory information and responses (Egner
and Hirsch, 2005). Furthermore, previous studies indicated
that the SFG and MFG are sensitive to OT administration in
patient populations. Among depressed individuals OT increased
activity in the SFG and MFG (Pincus et al., 2010) and among
children with autism OT increased activity in the MFG (Gordon
et al., 2013). Our findings, therefore, are consistent with the
current effort to specify the effects of OT on brain functioning
in different psychiatric conditions (Weisman and Feldman,
2013).
Our findings are also in line with research demonstrating
structural (Geuze et al., 2008; Tavanti et al., 2012) and
functional (Chung et al., 2006; Morey et al., 2008) alterations
in the SFG and MFG in patients with PTSD. Moreover,
the degree of alterations in these regions was found to
correlate with the severity of PTSD symptoms (Morey et al.,
2008; Tavanti et al., 2012). Our data similarly show that the
degree of SFG and MFG hypo-activity at baseline, indexed
by increased alpha activity, correlated with the number
of re-experiencing symptoms, including repeated flashbacks,
sensory-based memories, and uncontrolled reliving of trauma.
A negative correlation between spontaneous activity in the
dlPFC and re-experiencing symptoms has been reported
in a previous work (Yan et al., 2013) and it has been
suggested to be related to the role of this region in inhibiting
unwanted memories (Anderson et al., 2004; Yan et al., 2013).
Additionally, research has shown that increased activity in
SFG and MFG following cognitive behavior therapy was
related to PTSD symptom improvement (Lindauer et al.,
2008). Finally, evidence indicates that frontal alpha activity is
sensitive to therapy in PTSD (Kluetsch et al., 2014). Taken
together, these studies underscore the sensitivity of these
dorsolateral prefrontal regions to both symptom severity and
treatment effects in PTSD. This is in line with perspectives
suggesting that the prefrontal deficits in PTSD are not
innate but acquired following the onset of the disorder and
may thus be more amenable to intervention (Admon et al.,
2013).
We are aware of no prior study that examined the
effects of OT administration on brain response in trauma-
exposed combat veterans and the findings therefore suggest
that much further research is warranted to fully test the
potential beneficial effects of OT in this context. Our findings
that OT administration was effective for some individuals but
not for others is consistent with the general observation that
OT’s effect is influenced by various personal factors (Bartz
et al., 2011b), including the presence of psychiatric symptoms,
as demonstrated in a number of studies showing differential
effects of OT administration on brain activity among patients
and controls (Labuschagne et al., 2010; Pincus et al., 2010;
Dodhia et al., 2014). Such data strengthen the view of the
complex nature of OT (e.g., Bartz et al., 2011b; Weisman and
Feldman, 2013) and support the current call to implement
personalized intervention that is guided by the individual’s
symptomatology for targeted and effective treatments. Very little
research examined the involvement of the OT system in PTSD
and much further research is required. The observation that
OT’s effects are influenced by personal as well as contextual
factors (Bartz et al., 2011b) and importantly, are not always
positive (e.g., Bartz et al., 2011a; De Dreu et al., 2011; Shalvi
and De Dreu, 2014) emphasize the need to further examine
its effects in PTSD, also in other contexts, using different
experimental tasks, in addition to the currently used resting-state
assessment.
Overall, the high number of returning veterans with traumatic
war experiences and the vulnerability of this population to
develop PTSD (Kessler et al., 1995; Richardson et al., 2010),
underscore the importance and potential clinical utility of these
findings, but, at the same time, emphasize the preliminary
nature of our study. Much further research is required to
describe the effects of OT on oscillatory brain activity at rest
and in response to various tasks, to test mechanisms by which
OT impacts other neurohormonal systems, such as the HPA,
dopamine, or immune systems, and to specify the types of
psychological interventions that may work in concert with OT
to increase well-being among patients suffering from post-
traumatic distress.
Limitations
Several study limitations should be remembered in the
interpretation of the findings. First, although our study is
large for a brain study, involving 86 brain scans—among
the largest OT-administration brain studies—the number of
veterans with PTSD is relatively small and the findings require
further validation and specification before generalizability can
be made. Second, we specifically chose veterans who are young,
relatively functional, and free from medical illness, and further
research is required to test whether our findings generalize
to veterans with long-lasting PTSD, medical conditions, or
functional impairment. Next, some methodological concerns
regarding OT measurement should be considered. First, there
is still uncertainty as to what other molecules are possibly
being measured along with OT using the commonly applied
methods for OT levels determination, (i.e., RIA vs. EIA),
especially when pre-analysis extraction procedure is not included
(McCullough et al., 2013), as was the case in our study.
Further validation and standardization are needed to better
understand the meaning of these measures. Second, while
OT is released by the pituitary gland into the blood stream
and is presumed to be the primary source of salivary OT
(Carter et al., 2007), the relation between peripheral OT
measures and OT’s function within the CNS is still not
well understood; therefore, the physiological meaning of these
measures should be interpreted with caution. Considering
plasma vs. salivary OTmeasures, saliva sampling is advantageous
since it is a convenient, non-invasive and less stressful
procedure (Carter et al., 2007). However, the plasma measure
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is considered a more direct one, yet we found in several
studies that plasma and saliva measures show medium-level
correlations (Feldman et al., 2011). Finally, it is important
to complement brain activity in the absence of task (i.e.,
‘‘resting state’’) with response patterns to specific tasks related
to fear stimuli in general or to the individual’s specific
traumatic memories for a fuller understanding of brain
patterns underpinning PTSD and their response to oxytocin
administration.
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